Literature DB >> 15486599

Effective Recognition and Treatment of Generalized Anxiety Disorder in Primary Care.

.   

Abstract

This Academic Highlights section of The Primary Care Companion to The Journal of Clinical Psychiatry presents the highlights of the planning roundtable "Effective Recognition and Treatment of Generalized Anxiety Disorder (GAD) in the Primary Care Setting," held December 11, 2003, in Pittsburgh, Pa. The planning roundtable and this Academic Highlights were supported by an unrestricted educational grant from Pfizer. The planning roundtable was chaired by Larry Culpepper, M.D., M.P.H., Boston University School of Medicine, Boston, Mass. The faculty member was Kathryn M. Connor, M.D., Duke University Medical Center, Durham, N.C.

Entities:  

Year:  2004        PMID: 15486599      PMCID: PMC427612     

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  28 in total

Review 1.  Treatment of anxiety disorders to remission.

Authors:  J C Ballenger
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

Review 2.  Duloxetine pharmacology: profile of a dual monoamine modulator.

Authors:  Kelly D Karpa; Jane E Cavanaugh; Joan M Lakoski
Journal:  CNS Drug Rev       Date:  2002

3.  Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care.

Authors:  D Kessler; K Lloyd; G Lewis; D P Gray
Journal:  BMJ       Date:  1999-02-13

4.  Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.

Authors:  A C Pande; M Greiner; J B Adams; R B Lydiard; M W Pierce
Journal:  Biol Psychiatry       Date:  1999-09-15       Impact factor: 13.382

5.  Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs.

Authors:  W Katon; M Von Korff; E Lin; P Lipscomb; J Russo; E Wagner; E Polk
Journal:  Gen Hosp Psychiatry       Date:  1990-11       Impact factor: 3.238

6.  Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

Authors:  R C Kessler; C B Nelson; K A McGonagle; J Liu; M Swartz; D G Blazer
Journal:  Br J Psychiatry Suppl       Date:  1996-06

7.  Generalized anxiety and depression in primary care: prevalence, recognition, and management.

Authors:  Hans-Ulrich Wittchen; Ron C Kessler; Katja Beesdo; Petra Krause; Michael Höfler; Jürgen Hoyer
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

8.  The genetics of panic disorder and agoraphobia.

Authors:  R R Crowe
Journal:  Psychiatr Dev       Date:  1985

Review 9.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.

Authors:  G P Chrousos; P W Gold
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

10.  Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment.

Authors:  K Kroenke; R L Spitzer; J B Williams; M Linzer; S R Hahn; F V deGruy; D Brody
Journal:  Arch Fam Med       Date:  1994-09
View more
  5 in total

1.  Deep learning paired with wearable passive sensing data predicts deterioration in anxiety disorder symptoms across 17-18 years.

Authors:  Nicholas C Jacobson; Damien Lekkas; Raphael Huang; Natalie Thomas
Journal:  J Affect Disord       Date:  2020-12-27       Impact factor: 4.839

2.  The structure and reliability of the amharic version of the hospital anxiety and depression scale in orphan adolescents in addis ababa.

Authors:  Fentie Ambaw
Journal:  Ethiop J Health Sci       Date:  2011-03

3.  Correlates of worry and functional somatic symptoms in generalized anxiety disorder.

Authors:  Vijaya Kumar; Ajit Avasthi; Sandeep Grover
Journal:  Ind Psychiatry J       Date:  2019-12-11

4.  The Effects of Emotional Working Memory Training on Trait Anxiety.

Authors:  Gabrielle C Veloso; Welison Evenston G Ty
Journal:  Front Psychol       Date:  2021-01-13

5.  Predictors of premature discontinuation of treatment in multiple disease states.

Authors:  Eric Nantz; Hong Liu-Seifert; Vladimir Skljarevski
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.